This letter refutes the “overdiagnosis” narrative, blaming the stimulant shortage on DEA regulatory failures, clinical constraints, and recognition of historical underdiagnosis. By concluding that ...

Five take-home messages for GPs on the recognition and management of attention deficit hyperactivity disorder (ADHD) in ...

Agave Health announces the deployment of the Unified Protocol across its clinical care model, strengthening its structured approach to treating adult ADHD. Deploying the Unified Protocol allows Agave ...

New prescriptions for stimulants among adults, largely to treat ADHD, more than doubled since the start of the COVID-19 ...

The way ADHD is diagnosed and managed is changing across the country. Here's the reason for the change and how it will work in each state and territory.